Athersys Inc (NASDAQ:ATHX)

0.2301
Delayed Data
As of Aug 16
 -0.0108 / -4.31%
Today’s Change
0.17
Today|||52-Week Range
1.81
-74.51%
Year-to-Date
Athersys (ATHX) Q2 2022 Earnings Call Transcript
Aug 11 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close0.25
Today’s open0.25
Day’s range0.23 - 0.25
Volume6,113,668
Average volume (3 months)10,454,976
Market cap$68.1M
Data as of 3:55pm ET, 08/16/2022

Growth & Valuation

Earnings growth (last year)+7.71%
Earnings growth (this year)+35.90%
Earnings growth (next 5 years)+1.00%
Revenue growth (last year)+282.92%
P/E ratioNM
Price/Sales36.71
Price/Book3.83

Competitors

 Today’s
change
Today’s
% change
AVCOAvalon Globocare Cor...+0.01+1.67%
HARPHarpoon Therapeutics...-0.03-1.40%
APLTApplied Therapeutics...-0.07-5.11%
RUBYRubius Therapeutics ...-0.02-2.95%
Data as of 4:00pm ET, 08/16/2022

Financials

Next reporting dateNovember 9, 2022
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$5.5M
Annual profit (last year)-$87.0M
Net profit margin-1,576.99%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
Cleveland, Ohio

Forecasts